FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method

• Main Authors: Chadarat Ampasavate, Wasimon Jutapakdee, Rungsinee Phongpradist, Singkome Tima, Adisak Tantiworawit, Pimlak Charoenkwan, Dujrudee Chinwong, Songyot Anuchapreeda
• Format: Journal
• Published: 2019
• Subjects: Biochemistry, Genetics and Molecular Biology; Health Professions; Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065971444&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/65384
• Institution: Chiang Mai University

© 2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc. Background: Overexpression of fms-like tyrosine kinase 3 (FLT3) protein in leukemia is highly related to poor prognosis and reduced survival rate in acute myeloid leukemia (AML) and acute lymphoblastic...